Immutep (IMMP) said a Phase 2 study of efti in combination with radiotherapy and Merck's (MRK) Keytruda showed significant efficacy in treating patients with soft tissue sarcoma in the neoadjuvant ...

which causes tumors to grow in the tissue that covers nerves throughout the body. February 11, 2025 Germany's Merck in advanced talks to acquire US biotech firm SpringWorks Merck KGaA , the German ...